Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. - Wikidata - awgldk - TriplyDB

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

http://www.wikidata.org/entity/Q35160907

about

Atherosclerosis The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future CD40 in coronary artery disease: a matter of macrophages?The role of platelets in the recruitment of leukocytes during vascular disease The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis The influence of innate and adaptive immune responses on atherosclerosis T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions Intranasal delivery of E-selectin reduces atherosclerosis in ApoE-/- mice Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice.CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.Correlation between near-infrared Raman spectroscopy and the histopathological analysis of atherosclerosis in human coronary arteries.Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library.Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.CD40L and Its Receptors in Atherothrombosis-An Update Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans.CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.Microvascular thrombosis and CD40/CD40L signaling.Inflammatory bio-markers and cardiovascular risk prediction.Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.Beta3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice.Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system Platelets in inflammation and atherogenesis.Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis.Cardiovascular proteomics: past, present, and future.Cardiovascular disease, inflammation, and periodontal infection.T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice.miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40 Autoimmunity in atherosclerosis: a protective response losing control?CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation T-cell costimulation and coinhibition in atherosclerosis.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.

P2860

Q24644573-BA357D09-915C-4A17-9914-ED4572C7CA4B Q24673258-E126E3AE-6658-42C0-A001-7DD51E3556C4 Q26752784-07D65B36-A7EC-4273-8A0C-23FAE7A749E0 Q26801407-21C80BF0-2BE3-4B0E-8329-E98689647113 Q26996707-894DC022-6910-4194-950D-1369552807A8 Q27000370-31A6775E-754B-45F2-B608-B38AF595FBF8 Q28396774-F19F23BD-8851-41EE-A880-650ACA75948B Q28710388-B799F2B7-934F-4AC5-B5A0-3AE19E5945C5 Q28743431-63333AD2-9F4C-4D22-BCE5-B80F1DF87AC1 Q30405805-4A47B7D8-347C-43B1-9A38-599348AF103F Q30441065-77F23DD0-DDFD-44B9-BC0E-9C9CC5487EAF Q30497499-95EF1C3D-D02A-4577-BAB7-2906D2D336E4 Q30701029-8D686D2F-44C9-4011-B9C2-E484458D26D1 Q31100421-52C7DD94-99F7-4BD7-AC2E-F330E367B295 Q33183129-669A7608-BB1A-427D-AEBA-EA6C5946E935 Q33635135-68C21A41-64F6-4728-9470-DC7ACC57C233 Q33656103-945A3279-30F5-49BE-86D5-32EA119E3640 Q33715270-36FB4590-CD9F-426D-9AC9-7AA501E1F02A Q33814059-B679CEB3-7410-4248-8EA9-47E6AF3CC14E Q33996260-246D331C-A7B5-4B95-A19A-43FE0D6968BD Q34193651-A1418429-C8F7-4FC4-B2E4-5EA5C533369C Q34630514-89097638-A047-4DBF-9ADD-ECF63F0B96F3 Q34941391-5CCC4DD2-8067-4367-875B-49C1110160C5 Q34986368-3D9ECF1D-ED16-493E-B1CB-1675861FB906 Q35144122-78247E5D-A93B-4194-81AA-58E3780703BA Q35161070-01FCA46E-AD87-413B-9B1C-E05E5E1F21A1 Q35795164-2D8EA0DC-7C99-4ED8-964C-A986604D93AC Q35824531-514FFA86-785C-4438-BC4D-F31492CA88F3 Q35994774-1B984DA5-77FD-4C9D-8A3A-54FA5DD4C921 Q36216095-4F7918DF-4880-4E1F-93E4-68C08B58ABDC Q36328825-55BE2454-F2D8-4CF4-845F-F493EC557D58 Q36691050-DAAFB9D9-6A82-4716-AAEA-932D84F51C02 Q36775610-1AA4C8EF-7E3D-499D-8362-939B34D1580E Q36809182-015D71D5-FFBF-4481-AA09-30D36A67C0C1 Q36976746-A36A1AF2-09D3-4698-A36B-406C6C66815B Q37093868-D0965C5D-0DDC-4180-89C9-2666B2FAEB49 Q37138017-94AFB0C7-A70B-452C-85C8-D63FCFD20654 Q37138961-6941A50A-8512-4D20-A9A5-789F5873BCEE Q37143018-7D8DDA27-83C4-41E3-85C5-3E6CCD3D3535 Q37300823-376E5025-9FA7-4680-88ED-C00A46914D0A

P2860

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

http://www.wikidata.org/entity/Q35160907

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@ast

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@en

type

label

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@ast

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@en

prefLabel

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@ast

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@en

P1433

Q35160907-B35DC009-DC48-4513-9035-F82DE2F51493

P1476

Q35160907-26D8167C-9E12-4265-B5AE-FBF5D49F3124

P2093

Q35160907-1D4E34A6-7277-4F56-85E3-05F6B4E0D978

Q35160907-2EAB8ABA-8C53-4420-B6B8-DB6EB82ACABB

Q35160907-5F404151-C3CA-47CB-AA85-8E77D4EF2618

Q35160907-7224D9C2-0C51-4380-BA82-75D1EB12A172

Q35160907-945B29D0-6504-42D5-A5E6-516E7C866A60

P2860

Q35160907-02759DF0-8050-4065-8162-339310284CFB

Q35160907-02D26FDF-586E-4235-9F00-BF08551E6A8E

Q35160907-063BFD70-BBA9-44FF-A2C8-5F0A9DD13A21

Q35160907-0D9E1CBE-0659-4ACB-B559-8EDA0FEE8C06

Q35160907-0F4DC6D7-C18C-4079-9EDF-1595F886A6FD

Q35160907-1812B7E8-7BC0-4BAE-8A1E-327323F54242

Q35160907-1C492BD2-4006-4EDD-96F1-85921337CBF1

Q35160907-25330E4A-F650-487E-8760-C9B5FF6A7CF2

Q35160907-25E43B85-6D1A-4BDD-99FB-9BD114614A20

Q35160907-3ADC4562-69B6-490D-A3A9-432BFB441023

P304

Q35160907-1B1AB258-CE62-4681-89D8-B2D961EEF664

P31

Q35160907-B26EA157-EBA6-464B-8C96-DD42BE30D672

P356

Q35160907-F6A0E373-A3B7-482D-A042-78ABCCC6F4DD

P407

Q35160907-7E422704-65E3-4F2C-AB4B-E02378B581BF

P433

Q35160907-75F0AC3F-2899-4C0F-8606-047EFD43E9F4

P478

Q35160907-631F6E22-86FD-4486-B24F-B651F9D4D124

P577

Q35160907-035F3272-CD8D-4FFB-A996-299E9143ECB8

P5875

Q35160907-33F153F2-2EBF-43E7-8FB3-DA52E66ADEA1

P698

Q35160907-2306C5CA-8F31-483C-9E70-3F5A532A356B

P921

Q35160907-24F3F7C8-81A4-440A-9D5F-89B24E931231

P932

Q35160907-6F07AF08-1D69-4A00-A075-96A339C3C914

P356

PNAS.97.13.7458

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.

@en

P2093

F Mach

http://www.w3.org/2001/XMLSchema#string

G K Sukhova

http://www.w3.org/2001/XMLSchema#string

K Shimizu

http://www.w3.org/2001/XMLSchema#string

P Libby

http://www.w3.org/2001/XMLSchema#string

U Schönbeck

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)

Atherosclerosis — An Inflammatory Disease

Molecular and biological characterization of a murine ligand for CD40

A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells

Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.

Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.

The role of apoptosis in vascular disease.

The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

P304

7458-7463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.97.13.7458

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12457731

http://www.w3.org/2001/XMLSchema#string

P698

10861012

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

16567

http://www.w3.org/2001/XMLSchema#string